Prognostic Factors for Survival After Transarterial Chemoembolization Combined with Sorafenib in the Treatment of BCLC Stage B and C Hepatocellular Carcinomas-Reference-Cited by-同舟云学术

Prognostic Factors for Survival After Transarterial Chemoembolization Combined with Sorafenib in the Treatment of BCLC Stage B and C Hepatocellular Carcinomas

Published:2018-04 Issue:4 Volume:25 Page:423-429
ISSN:1076-6332
Container-title:Academic Radiology
language:en
Short-container-title:Academic Radiology

Author:

Ni Jia-yan,Kong Jian,Sun Hong-liang,Chen Yao-ting,Luo Jiang-hong,Wang Wei-dong,Chen Dong,Jiang Xiong-ying,Xu Lin-feng^ORCID

Funder

Guangzhou Bureau of Science and Information Technology

Guangdong Higher Education Institutes

Publisher

Elsevier BV

Subject

Radiology, Nuclear Medicine and imaging

Reference34 articles.

1. The evolving epidemiology of hepatocellular carcinoma: a global perspective;Wallace;Expert Rev Gastroenterol Hepatol,2015

2. Hepatobiliary tumors: update on diagnosis and management;Kabbach;J Clin Transl Hepatol,2015

3. The incidence and epidemiology of hepatocellular carcinoma: a global and regional perspective;Venook;Oncologist,2010

4. Management of hepatocellular carcinoma: an update;Bruix;Hepatology,2011

5. Position paper of the Italian Association for the Study of the Liver (AISF): the multidisciplinary clinical approach to hepatocellular carcinoma;Italian Association for the Study of the Liver (AISF);Dig Liver Dis,2013

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Examining the Efficacy and Safety of Combined Locoregional Therapy and Immunotherapy in Treating Hepatocellular Carcinoma;Biomedicines;2024-06-27

2. A new model to estimate duration of survival in patients with hepatocellular carcinoma with BCLC intermediate stage;Scientific Reports;2023-11-25

3. Analysis and prediction of the efficacy and influencing factors of camrelizumab combined with TACE and sorafenib in the treatment of advanced hepatocellular carcinoma;Journal of Cancer Research and Clinical Oncology;2023-07-14

4. Analysis and prediction of the efficacy and influencing factors of camrelizumab combined with TACE and sorafenib in the treatment of advanced hepatocellular carcinoma;2023-05-22

5. Effectiveness of c-TACE Combined With Sorafenib Versus c-TACE Monotherapy in Advanced Hepatocellular Carcinoma: A Retrospective Study;Clinical Medicine Insights: Oncology;2023-01